These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36449947)

  • 21. Discovery of Thieno[2,3-
    Pan Z; Li X; Wang Y; Jiang Q; Jiang L; Zhang M; Zhang N; Wu F; Liu B; He G
    J Med Chem; 2020 Apr; 63(7):3678-3700. PubMed ID: 32153186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Harmine-based dual inhibitors targeting histone deacetylase (HDAC) and DNA as a promising strategy for cancer therapy.
    Lu D; Qu L; Wang C; Luo H; Li S; Yin F; Liu X; Chen X; Luo Z; Cui N; Peng W; Ji L; Kong L; Wang X
    Bioorg Chem; 2022 Mar; 120():105604. PubMed ID: 35051708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines.
    Sixto-López Y; Gómez-Vidal JA; de Pedro N; Bello M; Rosales-Hernández MC; Correa-Basurto J
    Sci Rep; 2020 Jun; 10(1):10462. PubMed ID: 32591593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and preliminary bioactivity evaluation of N-benzylpyrimidin-2-amine derivatives as novel histone deacetylase inhibitor.
    Zhou Y; Dun Y; Fu H; Wang L; Pan X; Yang X; Fang H
    Chem Biol Drug Des; 2017 Nov; 90(5):936-942. PubMed ID: 28489276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Pyrazine-Anilinobenzamides as Histone Deacetylase HDAC1-3 Selective Inhibitors and Biological Testing Against Pancreas Cancer Cell Lines.
    Abdelsalam M; Ibrahim HS; Krauss L; Zessin M; Vecchio A; Hastreiter S; Schutkowski M; Schneider G; Sippl W
    Methods Mol Biol; 2023; 2589():145-155. PubMed ID: 36255623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and evaluation of novel HDAC inhibitors as potential antitumor agents.
    Cheng J; Qin J; Guo S; Qiu H; Zhong Y
    Bioorg Med Chem Lett; 2014 Oct; 24(19):4768-4772. PubMed ID: 25182565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors.
    Tavares MT; de Almeida LC; Kronenberger T; Monteiro Ferreira G; Fujii de Divitiis T; Franco Zannini Junqueira Toledo M; Mariko Aymoto Hassimotto N; Agostinho Machado-Neto J; Veras Costa-Lotufo L; Parise-Filho R
    Bioorg Med Chem; 2021 Apr; 35():116085. PubMed ID: 33668008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of Novel 1,2,3,4-Tetrahydrobenzofuro[2,3-
    Lai Z; Ni H; Hu X; Cui S
    J Med Chem; 2023 Aug; 66(15):10791-10807. PubMed ID: 37498552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of Novel Pyrrolo[2,3-
    Liang X; Tang S; Liu X; Liu Y; Xu Q; Wang X; Saidahmatov A; Li C; Wang J; Zhou Y; Zhang Y; Geng M; Huang M; Liu H
    J Med Chem; 2022 Jan; 65(2):1243-1264. PubMed ID: 33586434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and synthesis of a new generation of substituted purine hydroxamate analogs as histone deacetylase inhibitors.
    Liu R; Wang J; Tang W; Fang H
    Bioorg Med Chem; 2016 Apr; 24(7):1446-54. PubMed ID: 26907204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based design, synthesis and in vitro antiproliferative effects studies of novel dual BRD4/HDAC inhibitors.
    Shao M; He L; Zheng L; Huang L; Zhou Y; Wang T; Chen Y; Shen M; Wang F; Yang Z; Chen L
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4051-4055. PubMed ID: 28765013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and anticancer activities of novel dual poly(ADP-ribose) polymerase-1/histone deacetylase-1 inhibitors.
    Tian Y; Xie Z; Liao C
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127036. PubMed ID: 32088129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent Progress in Histone Deacetylase (HDAC) 1 Inhibitors as Anticancer Agent.
    Patel P; Wahan SK; Vishakha S; Kurmi BD; Gupta GD; Rajak H; Asati V
    Curr Cancer Drug Targets; 2022; 23(1):47-70. PubMed ID: 35747969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved antiproliferative activity of 1,3,4-thiadiazole-containing histone deacetylase (HDAC) inhibitors by introduction of the heteroaromatic surface recognition motif.
    Guan P; Wang L; Hou X; Wan Y; Xu W; Tang W; Fang H
    Bioorg Med Chem; 2014 Nov; 22(21):5766-75. PubMed ID: 25311567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of adamantane based highly potent HDAC inhibitors.
    Gopalan B; Ponpandian T; Kachhadia V; Bharathimohan K; Vignesh R; Sivasudar V; Narayanan S; Mandar B; Praveen R; Saranya N; Rajagopal S; Rajagopal S
    Bioorg Med Chem Lett; 2013 May; 23(9):2532-7. PubMed ID: 23538115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and biological evaluation of novel c-Met/HDAC dual inhibitors.
    Dong Y; Hu H; Sun Y; Qin M; Gong P; Hou Y; Zhao Y
    Bioorg Med Chem Lett; 2020 Dec; 30(23):127610. PubMed ID: 33045329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and biological evaluation of novel indazole-based derivatives as potent HDAC inhibitors via fragment-based virtual screening.
    Liu J; Zhou J; He F; Gao L; Wen Y; Gao L; Wang P; Kang D; Hu L
    Eur J Med Chem; 2020 Apr; 192():112189. PubMed ID: 32151834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery and SAR analysis of 5-chloro-4-((substituted phenyl)amino)pyrimidine bearing histone deacetylase inhibitors.
    Zhang L; Chen Y; Li F; Zhang L; Feng J; Zhang L
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1918-1927. PubMed ID: 35833370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multimodal HDAC Inhibitors with Improved Anticancer Activity.
    Schobert R; Biersack B
    Curr Cancer Drug Targets; 2018; 18(1):39-56. PubMed ID: 28176653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NO-HDAC dual inhibitors.
    Omidkhah N; Ghodsi R
    Eur J Med Chem; 2022 Jan; 227():113934. PubMed ID: 34700268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.